The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(2-cyano-5-(trifluoromethoxy)phenyl)-3-azaspiro[5.5]undecan-9-yl)acetic acid ID: ALA3973034
PubChem CID: 73777156
Max Phase: Preclinical
Molecular Formula: C20H23F3N2O3
Molecular Weight: 396.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(OC(F)(F)F)cc1N1CCC2(CCC(CC(=O)O)CC2)CC1
Standard InChI: InChI=1S/C20H23F3N2O3/c21-20(22,23)28-16-2-1-15(13-24)17(12-16)25-9-7-19(8-10-25)5-3-14(4-6-19)11-18(26)27/h1-2,12,14H,3-11H2,(H,26,27)
Standard InChI Key: SXNLLFZBIQFVNA-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
11.4564 -5.5508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0216 -3.9058 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.7404 -5.1409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8733 -10.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8879 -6.3714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1714 -7.6076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1732 -5.1339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8624 -12.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1508 -11.7294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8835 -8.8492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8565 -12.9720 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4463 -10.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8797 -9.6695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1567 -10.9043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6018 -6.7852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4594 -8.8492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1714 -6.7825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5798 -11.7395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8883 -5.5472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8835 -8.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1677 -9.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7376 -4.3158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4594 -8.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4506 -3.9008 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.7301 -3.4908 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.4510 -9.6659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4596 -6.3738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3088 -7.1949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9 8 1 0
12 14 1 0
7 1 1 0
22 25 1 0
17 5 2 0
4 13 1 0
26 12 1 0
21 10 1 0
21 26 1 0
22 2 1 0
5 19 1 0
8 18 1 0
16 21 1 0
1 3 1 0
23 6 1 0
20 6 1 0
14 9 1 0
21 13 1 0
6 17 1 0
10 20 1 0
14 4 1 0
8 11 2 0
27 17 1 0
22 24 1 0
3 22 1 0
19 7 2 0
5 15 1 0
23 16 1 0
1 27 2 0
15 28 3 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.41Molecular Weight (Monoisotopic): 396.1661AlogP: 4.71#Rotatable Bonds: 4Polar Surface Area: 73.56Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.66CX Basic pKa: 1.31CX LogP: 5.09CX LogD: 2.41Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.80Np Likeness Score: -0.66
References 1. Cox JM, Chu HD, Chelliah MV, Debenham JS, Eagen K, Lan P, Lombardo M, London C, Plotkin MA, Shah U, Sun Z, Vaccaro HM, Venkatraman S, Suzuki T, Wang N, Ashley ER, Crespo A, Madeira M, Leung DH, Alleyne C, Ogawa AM, Souza S, Thomas-Fowlkes B, Di Salvo J, Weinglass A, Kirkland M, Pachanski M, Powles MA, Tozzo E, Akiyama TE, Ujjainwalla F, Tata JR, Sinz CJ.. (2017) Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists., 8 (1): [PMID:28105274 ] [10.1021/acsmedchemlett.6b00360 ]